Episode Details

Back to Episodes
A 360° Glaucoma Procedure Beat Simple Needle Goniotomy at 2 Years — How Effective Is GATT Really?

A 360° Glaucoma Procedure Beat Simple Needle Goniotomy at 2 Years — How Effective Is GATT Really?

Published 1 month, 2 weeks ago
Description

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/a-360-glaucoma-procedure-beat-simple-needle-goniotomy-at-2-years-how-effective-is-gatt-really

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

A 360° Glaucoma Procedure Beat Simple Needle Goniotomy at 2 Years — How Effective Is GATT Really? Introduction Opening the eye’s natural drainage pathway all the way around sounds as though it should lower pressure more than opening only one small section. A randomized trial published on September 28, 2026 offers a rare direct comparison: gonioscopy-assisted transluminal trabeculotomy, which opens the drainage pathway through 360 degrees, versus a 90-degree procedure using a bent needle. At two years, the full-circle procedure had better average pressure and medication results. But the trial does not prove that treating more degrees alone caused the advantage. The treatments differed in both extent and technique, and the study was small. Its results support gonioscopy-assisted transluminal trabeculotomy as a promising option for selected patients—not as a guarantee of very low pressure or freedom from future treatment. The 2026 randomized trial by Ayub and Costa () What the randomized trial actually studied The trial enrolled 45 eyes from 34 adults at two centers in Brazil. Participants had mild-to-moderate primary open-angle glaucoma, were 40 to 80 years old, had already undergone cataract surgery, and were using no more than three pressure-lowering medicines. Their treated pressure had to be at least 18 millimeters of mercury at two visits. The researchers assigned 23 eyes to gonioscopy-assisted transluminal trabeculotomy (GATT) and 22 to bent ab interno needle goniotomy (BANG). Patients were masked to their procedure, but the surgeons and examiners could identify it. The same experienced surgeon performed all operations. In the full-circle procedure, the surgeon passed a suture around Schlemm’s canal and pulled it through, opening the trabecular meshwork through 360 degrees. The needle procedure removed a strip of tissue over approximately 90 degrees of the nasal angle. So this was not a comparison of the same operation at two different widths: both the instrument and the amount of tissue treated differed. Trial methods and eligibility criteria () Baseline pressure: two different starting points Before surgery, the average pressure while patients were still using their medicines was 19.87 millimeters of mercury in the GATT group and 21.18 in the BANG group. After a medication washout, the averages were much higher and almost identical: 25.43 and 25.55, respectively. The difference between the groups’ treated pressures was not statistically significant, but it matters when interpreting percentage reductions. The average medication burden was also similar: 2.35 medicines in the GATT group and 2.41 in the BANG group. Participants were mostly older adults, with an average age of about 73; the average visual-field loss was mild, and all eyes were pseudophakic, meaning they had an artificial lens after cataract surgery. Baseline data reported for the trial () Two-year results: GATT did better, but the details matter At 24 months, average pressure was 15.41 millimeters of mercury after GATT and 17.79 after BANG. The paper reported reductions from the on-treatment baseline of 22.44% and 16.0%, respectively. Because the GATT group started with a treated average about 1.3 millimeters lower, the difference in the absolute change from those baselines was smaller than the endpoi

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us